Cargando…
Evaluation of three rapid lateral flow antigen detection tests for the diagnosis of SARS-CoV-2 infection
INTRODUCTION: The COVID-19 pandemic has led to high demand of diagnostic tools. Rapid antigen detection tests have been developed and many have received regulatory acceptance such as CE IVD or FDA markings. Their performance needs to be carefully assessed. MATERIALS AND METHODS: 158 positive and 40...
Autores principales: | Jääskeläinen, A.E., Ahava, M.J., Jokela, P., Szirovicza, L., Pohjala, S., Vapalahti, O., Lappalainen, M., Hepojoki, J., Kurkela, S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7934791/ https://www.ncbi.nlm.nih.gov/pubmed/33711694 http://dx.doi.org/10.1016/j.jcv.2021.104785 |
Ejemplares similares
-
A Generic, Scalable, and Rapid Time-Resolved Förster Resonance Energy Transfer-Based Assay for Antigen Detection—SARS-CoV-2 as a Proof of Concept
por: Rusanen, Juuso, et al.
Publicado: (2021) -
Rapid increase in SARS-CoV-2 seroprevalence during the emergence of Omicron variant, Finland
por: Ahava, Maarit J., et al.
Publicado: (2022) -
Detection of SARS-CoV-2 nucleocapsid antigen from serum can aid in timing of COVID-19 infection
por: Ahava, M.J., et al.
Publicado: (2022) -
Performance of six SARS-CoV-2 immunoassays in comparison with microneutralisation
por: Jääskeläinen, AJ, et al.
Publicado: (2020) -
SARS-CoV-2 sample-to-answer nucleic acid testing in a tertiary care emergency department: evaluation and utility
por: Jokela, Pia, et al.
Publicado: (2020)